Stock News: Analyst Moves for October 20 - PFE, JMP, GSK & More

Before today’s opening bell, a number of big-name dividend stocks were the subject of analyst moves. Below we highlight the most important analyst commentary for investors.

1. Pfizer Upgraded by Cowen

Cowen upgraded Pfizer (PFE ) from Market Perform to Outperform, with a price target of $43 (from $35). Shares of Pfizer closed at $34.50 yesterday. The company pays an annual dividend of $1.12 (paid quarterly) and has a yield of 3.25%.

2. Select Medical Holdings Upgraded by JMP Securities

JMP Securities upgraded Select Medical Holdings (JMP ) from Market Underperform to Market Perform. Shares of Select Medical Holdings closed at $10.78 yesterday. The company pays an annual dividend of 40 cents (paid quarterly) and has a yield of 3.71%.

3. GlaxoSmithKline Upgraded by Credit Suisse

Credit Suisse upgraded GlaxoSmithKline (GSK ) from Underperform to Neutral. The price target is unchanged. Shares of GlaxoSmithKline closed at $41.74 yesterday. The company pays an annual dividend of $2.35 (paid quarterly) and has a yield of 5.63%.

4. Cummins Downgraded by UBS

UBS downgraded Cummins (CMI ) from Buy to Neutral. Shares of Cummins closed at $108.57 yesterday. The company pays an annual dividend of $3.90 (paid quarterly) and has a yield of 3.59%.

5. PACCAR Downgraded by UBS

UBS downgraded PACCAR (PCAR ) from Buy to Neutral. Shares of PACCAR closed at $52.26 yesterday. The company pays an annual dividend of 96 cents (paid quarterly) and has a yield of 1.84%.